Identification of an Unusual Pattern of Global Gene Expression in Group B Streptococcus Grown in Human Blood

Because passage of the bacterium to blood is a crucial step in the pathogenesis of many group B Streptococcus (GBS) invasive infections, we recently conducted a whole-genome transcriptome analysis during GBS incubation ex vivo with human blood. In the current work, we sought to analyze in detail the difference in GBS gene expression that occurred in one blood sample (donor A) relative to other blood samples. We incubated GBS strain NEM316 with fresh heparinized human blood obtained from healthy volunteers, and analyzed GBS genome expression and cytokine production. Principal component analysis identified extensive clustering of the transcriptome data among all samples at time 0. In striking contrast, the whole bacterial gene expression in the donor A blood sample was significantly different from the gene expression in all other blood samples studied, both after 30 and 90 min of incubation. More genes were up-regulated in donor A blood relative to the other samples, at 30 min and 90 min. Furthermore, there was significant variation in transcript levels between donor A blood and other blood samples. Notably, genes with the highest transcript levels in donor A blood were those involved in carbohydrate metabolism. We also discovered an unusual production of proinflammatory and immunomodulatory cytokines: MIF, tPAI-1 and IL-1β were produced at higher levels in donor A blood relative to the other blood samples, whereas GM-CSF, TNF-α, IFN-γ, IL-7 and IL-10 remained at lower levels in donor A blood. Potential reasons for our observations are that the immune response of donor A significantly influenced the bacterial transcriptome, or both GBS gene expression and immune response were influenced by the metabolic status of donor A.

[1]  J. Musser,et al.  Extensive Adaptive Changes Occur in the Transcriptome of Streptococcus agalactiae (Group B Streptococcus) in Response to Incubation with Human Blood , 2008, PloS one.

[2]  A. Shapiro,et al.  The role of macrophage migration inhibitory factor on glucose metabolism and diabetes , 2008, Diabetologia.

[3]  J. Musser,et al.  A direct link between carbohydrate utilization and virulence in the major human pathogen group A Streptococcus , 2008, Proceedings of the National Academy of Sciences.

[4]  R. Katial,et al.  Cytokine Production in Cell Culture by Peripheral Blood Mononuclear Cells from Immunocompetent Hosts , 1998, Clinical Diagnostic Laboratory Immunology.

[5]  G. Bruant,et al.  Acquisition of Insertion Sequences and the GBSi1 Intron by Streptococcus agalactiae Isolates Correlates with the Evolution of the Species , 2005, Journal of bacteriology.

[6]  S. Haffner,et al.  Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. , 2002, Diabetes.

[7]  M. Caparon,et al.  A novel adaptation of aldolase regulates virulence in Streptococcus pyogenes , 2006, The EMBO journal.

[8]  W. Hop,et al.  The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock. , 1996, The Journal of infectious diseases.

[9]  T. Calandra.  Macrophage Migration Inhibitory Factor and Host Innate Immune Responses to Microbes , 2003, Scandinavian journal of infectious diseases.

[10]  J. Hokanson,et al.  The Insulin Resistance Atherosclerosis Study Family Study , 2004 .

[11]  S. Mauerer,et al.  Heterogeneity of Hemolysin Expression during Neonatal Streptococcus agalactiae Sepsis , 2007, Journal of Clinical Microbiology.

[12]  Carmen Buchrieser,et al.  Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease , 2002, Molecular microbiology.

[13]  J. McCarthy,et al.  Common infections in diabetes: pathogenesis, management and relationship to glycaemic control , 2007, Diabetes/metabolism research and reviews.

[14]  G. Bruant,et al.  Mobile Genetic Elements Provide Evidence for a Bovine Origin of Clonal Complex 17 of Streptococcus agalactiae , 2007, Applied and Environmental Microbiology.

[15]  V. Nizet,et al.  Bacterial Phenotype Variants in Group B Streptococcal Toxic Shock Syndrome , 2009, Emerging infectious diseases.

[16]  D. Grobbee,et al.  Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes. , 2002, Diabetes care.

[17]  W. Schaffner,et al.  Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. , 2008, JAMA.

[18]  J. Bernhagen,et al.  The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor , 1994, The Journal of experimental medicine.

[19]  M. Poggi,et al.  Plasminogen activator inhibitor-1, adipose tissue and insulin resistance , 2007, Current opinion in lipidology.

[20]  J. Musser,et al.  Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Lori A. S. Snyder,et al.  Genetic islands of Streptococcus agalactiae strains NEM316 and 2603VR and their presence in other Group B Streptococcal strains , 2005, BMC Microbiology.

[22]  A. Norrby-Teglund,et al.  Association of Human Leukocyte Antigen with Outcomes of Infectious Diseases: The Streptococcal Experience , 2003, Scandinavian journal of infectious diseases.

[23]  C. Baker,et al.  Group B streptococcal infections in elderly adults. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  J. Musser,et al.  Longitudinal analysis of the group A Streptococcus transcriptome in experimental pharyngitis in cynomolgus macaques. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[25]  T. Peto,et al.  Hyperinvasive Neonatal Group B Streptococcus Has Arisen from a Bovine Ancestor , 2004, Journal of Clinical Microbiology.

[26]  J. Musser,et al.  Remodeling of the Streptococcus agalactiae Transcriptome in Response to Growth Temperature , 2008, PloS one.

[27]  Philippe Glaser,et al.  Multilocus Sequence Typing System for Group B Streptococcus , 2003, Journal of Clinical Microbiology.

[28]  J. Musser,et al.  Toward a genome-wide systems biology analysis of host-pathogen interactions in group A Streptococcus. , 2005, The American journal of pathology.

[29]  E. Fikrig,et al.  Borrelia burgdorferi Changes Its Surface Antigenic Expression in Response to Host Immune Responses , 2004, Infection and Immunity.

[30]  M. Imamura,et al.  Elevated serum content of macrophage migration inhibitory factor in patients with type 2 diabetes. , 2000, Diabetes care.

[31]  N. L. van der Mee-Marquet,et al.  Molecular Characterization of Human-Colonizing Streptococcus agalactiae Strains Isolated from Throat, Skin, Anal Margin, and Genital Body Sites , 2008, Journal of Clinical Microbiology.

[32]  S. Chatellier,et al.  tRNA gene clusters at the 3' end of rRNA operons are specific to virulent subgroups of Streptococcus agalactiae strains, as demonstrated by molecular differential analysis at the population level. , 2002, Microbiology.

[33]  Yee‐Shin Lin,et al.  The severity of Streptococcus pyogenes infections in children is significantly associated with plasma levels of inflammatory cytokines. , 2008, Diagnostic microbiology and infectious disease.

[34]  L. Hammitt,et al.  Phylogenetic classification of serotype III group B streptococci on the basis of hylB gene analysis and DNA sequences specific to restriction digest pattern type III-3. , 2001, The Journal of infectious diseases.